These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18324347)

  • 1. Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors.
    Eriksson J; Stålberg P; Nilsson A; Krause J; Lundberg C; Skogseid B; Granberg D; Eriksson B; Akerström G; Hellman P
    World J Surg; 2008 May; 32(5):930-8. PubMed ID: 18324347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive surgery for metastatic liver neuroendocrine tumors.
    Norton JA; Warren RS; Kelly MG; Zuraek MB; Jensen RT
    Surgery; 2003 Dec; 134(6):1057-63; discussion 1063-5. PubMed ID: 14668741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal carcinoid tumors: factors that predict outcome.
    Van Gompel JJ; Sippel RS; Warner TF; Chen H
    World J Surg; 2004 Apr; 28(4):387-92. PubMed ID: 14994141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic surgery for metastases from neuroendocrine tumors.
    Sarmiento JM; Que FG
    Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors.
    Hellman P; Ladjevardi S; Skogseid B; Akerström G; Elvin A
    World J Surg; 2002 Aug; 26(8):1052-6. PubMed ID: 12016482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years.
    Nave H; Mössinger E; Feist H; Lang H; Raab H
    Surgery; 2001 Feb; 129(2):170-5. PubMed ID: 11174710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.
    Elias D; Goéré D; Leroux G; Dromain C; Leboulleux S; de Baere T; Ducreux M; Baudin E
    Eur J Surg Oncol; 2009 Oct; 35(10):1092-7. PubMed ID: 19464140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma.
    Lee SJ; Kim JH; Kim SY; Won HJ; Shin YM; Kim PN
    Korean J Radiol; 2020 Mar; 21(3):316-324. PubMed ID: 32090524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors.
    Makridis C; Rastad J; Oberg K; Akerström G
    World J Surg; 1996 Sep; 20(7):900-6; discussion 907. PubMed ID: 8678969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.
    Mazzaglia PJ; Berber E; Milas M; Siperstein AE
    Surgery; 2007 Jul; 142(1):10-9. PubMed ID: 17629995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors.
    Jensen EH; Kvols L; McLoughlin JM; Lewis JM; Alvarado MD; Yeatman T; Malafa M; Shibata D
    Ann Surg Oncol; 2007 Feb; 14(2):780-5. PubMed ID: 17146740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
    Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
    In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors.
    Søreide O; Berstad T; Bakka A; Schrumpf E; Hanssen LE; Engh V; Bergan A; Flatmark A
    Surgery; 1992 Jan; 111(1):48-54. PubMed ID: 1728075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-guided radiofrequency ablation (RFA) for inoperable gastrointestinal liver metastases.
    Hofer S; Oberholzer C; Beck S; Looser C; Ludwig C
    Ultraschall Med; 2008 Aug; 29(4):388-92. PubMed ID: 18785319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative management strategies of advanced gastrointestinal carcinoid neoplasms.
    Sartori P; Mussi C; Angelini C; Crippa S; Caprotti R; Uggeri F
    Langenbecks Arch Surg; 2005 Sep; 390(5):391-6. PubMed ID: 15968542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of carcinoid tumors of the stomach, duodenum, and pancreas.
    Akerström G
    World J Surg; 1996 Feb; 20(2):173-82. PubMed ID: 8661814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
    Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
    Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors.
    Eriksson B; Bergström M; Lilja A; Ahlström H; Långström B; Oberg K
    Acta Oncol; 1993; 32(2):189-96. PubMed ID: 7686763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of neuroendocrine tumors (including carcinoid).
    Doherty G
    Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):32-6. PubMed ID: 23183358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDOPA PET/CT-Guided Radiofrequency Ablation of Liver Metastases from Neuroendocrine Tumours: Technical Note on a Preliminary Experience.
    Cazzato RL; Garnon J; Ramamurthy N; Tsoumakidou G; Imperiale A; Namer IJ; Bachellier P; Caudrelier J; Rao P; Koch G; Gangi A
    Cardiovasc Intervent Radiol; 2016 Sep; 39(9):1315-21. PubMed ID: 27048487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.